American Journal of Preventive Cardiology

AUG 11, 2026 · JOURNAL ARTICLE

Clinical considerations on the use of evinacumab for the treatment of homozygous familial hypercholesterolemia.

American Journal of Preventive Cardiology

Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disorder that results in severely elevated low-density lipoprotein cholesterol (LDL-C) due to dysfunctional activi

AUG 9, 2026 · JOURNAL ARTICLE

Diet patterns are associated with progression of coronary artery calcification and differ across race/ethnicity: The Multi-Ethnic Study of Atherosclerosis.

American Journal of Preventive Cardiology

Inference regarding the longitudinal association between diet and coronary artery calcification (CAC) progression is limited, particularly when using empirically derived dietary pa

AUG 7, 2026 · JOURNAL ARTICLE

Dietary Risks and Cardiometabolic Disease Burden Across the United States: Geographic Inequalities, Age-Period-Cohort Patterns, and Projections to 2045.

American Journal of Preventive Cardiology

Diet and nutrition remain significant but modifiable drivers of cardiometabolic diseases (CMDs), yet the contemporary burden and future impact of diet-attributable CMDs in the Unit

AUG 6, 2026 · JOURNAL ARTICLE

Study design, rationale, and baseline characteristics of ATTAIN-HYPERTENSION, a phase 3 trial of the oral GLP-1 receptor agonist orforglipron for hypertension.

American Journal of Preventive Cardiology

Up to three-quarters of primary hypertension is epidemiologically attributed to excess adiposity. Incretin-based therapies are consistently associated with reduced blood pressure (

AUG 6, 2026 · JOURNAL ARTICLE

Circulating PCSK9 as a sex-stratified predictor in primary prevention of cardiovascular disease: Insights from a prospective cohort study in Chinese adults.

American Journal of Preventive Cardiology

While proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as an effective therapeutic target in secondary prevention of cardiovascular disease (CVD), its role in prim

JUL 30, 2026 · JOURNAL ARTICLE

Scaling a Lipid-Lowering Clinical Decision Support Intervention Across U.S. Health Systems: Lessons Learned from the PROMPT-LIPID Multicenter Study.

American Journal of Preventive Cardiology

The PRagmatic study Of Messaging to Providers about Treatment of HyperLIPIDemia (PROMPT-LIPID) single-system pragmatic, randomized trial demonstrated that an electronic health reco

JUL 28, 2026 · JOURNAL ARTICLE

Pro-inflammatory cytokines moderated by visceral adiposity from a pragmatic randomized crossover trial of portable HEPA air purifiers.

American Journal of Preventive Cardiology

Airborne particulate matter (PM) increases the risk of cardiovascular disease. High efficiency particulate arrestance (HEPA) filtration can reduce indoor PM, but evidence is lackin

JUL 28, 2026 · JOURNAL ARTICLE

Factors associated with patient preferences for statin therapy in primary prevention.

American Journal of Preventive Cardiology

The smallest worthwhile difference (SWD) - the minimum absolute benefit required to justify a treatment against its burdens - varies by personal preference. We investigated factors